Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to BTAI Full portfolio

Position in BTAI

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$210,400
+$189,806 QoQ
Shares Held
149,220
+1211.5% QoQ
Ownership
0.477%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 47 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Derivatives in BTAI

reported options exposure · as of Dec 31, 2024
CallValue
$12,903
CallShares
2,156
PutValue
$22,215
PutShares
3,712

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names. BTAI ranks #47 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in BTAI

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $210,400 149,220
2025-06-30 $20,594 11,378
2024-12-31 $12,903 34,500
2024-12-31 $22,215 59,400
2024-09-30 $16,897 27,700
2024-09-30 $13,542 22,200
2024-06-30 $84,224 65,800
2024-06-30 $26,240 20,500
2024-03-31 $114,613 40,643
2024-03-31 $33,558 11,900
2024-03-31 $219,114 77,700
2023-12-31 $262,255 88,900
2023-12-31 $169,625 57,500
2023-12-31 $15,723 5,330
2023-09-30 $36,179 14,300
2023-09-30 $270,710 107,000
2023-09-30 $84,502 33,400
2023-06-30 $576,090 86,500
2023-06-30 $658,008 98,800
2023-06-30 $96,763 14,529
2023-03-31 $770,658 41,300
2023-03-31 $1,575,500 84,432
2023-03-31 $263,106 14,100
2022-12-31 $2,012,676 93,700
2022-12-31 $1,001,204 46,611
2022-12-31 $494,040 23,000
2022-09-30 $236,400 20,000
2022-09-30 $674,850 57,094
2022-09-30 $1,271,832 107,600
2022-06-30 $580,232 43,957
2022-06-30 $555,720 42,100
2022-06-30 $1,314,720 99,600
2022-03-31 $1,699,983 81,300
2022-03-31 $763,215 36,500
2022-03-31 $997,678 47,713
2021-12-31 $2,185,475 107,500
2021-12-31 $1,317,384 64,800
2021-12-31 $972,363 47,829
2021-09-30 $1,004,888 33,110
2021-09-30 $1,902,945 62,700
2021-09-30 $2,200,375 72,500
2021-06-30 $2,365,484 81,400
2021-06-30 $1,269,922 43,700
2021-06-30 $2,315,239 79,671
2021-03-31 $2,602,548 60,300
2021-03-31 $3,055,252 70,789
2021-03-31 $1,782,508 41,300
2020-12-31 $3,358,740 72,700
2020-12-31 $2,236,080 48,400
2020-12-31 $37,617,979 814,242